Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

New Drug Application (NDA): 020803
Company: BAUSCH AND LOMB
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ALREX LOTEPREDNOL ETABONATE 0.2% SUSPENSION/DROPS;OPHTHALMIC Prescription None Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
03/09/1998 ORIG-1 Approval Type 1 - New Molecular Entity STANDARD Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20803lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20803ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020803_alrex_toc.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
12/16/2013 SUPPL-26 Manufacturing (CMC)

Label is not available on this site.

10/09/2013 SUPPL-25 Manufacturing (CMC)

Label is not available on this site.

08/30/2001 SUPPL-4 Manufacturing (CMC)-Control

Label is not available on this site.

07/18/2000 SUPPL-3 Manufacturing (CMC)-Control

Label is not available on this site.

08/17/1999 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

05/19/1999 SUPPL-1 Manufacturing (CMC)-Control

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
03/09/1998 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20803lbl.pdf

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English